Skip to main content

Table 1 Patient characteristics

From: Development and validation of a population pharmacokinetic model of vancomycin for patients of advanced age

Characteristics

Modeling dataset (n = 159)

Number (%) or median (min–max)

Validation dataset (n = 133)

Number (%) or median (min–max)

Age (years)

84 (75–99)

81 (75–101)

 75–84

80 (50.3)

86 (64.7)

 85–94

73 (45.9)

46 (34.6)

 ≥ 95

6 (3.8)

1 (0.8)

Sex (male/female)

92 (57.9)/67 (42.1)

69 (51.9)/64 (48.1)

Height (cm)

158 (135–180)

157 (137–182)

Body weight (kg)

47 (26–70)

49 (29–70)

Body Mass Index (kg/m2)

18.6 (11.0–24.8)

20.0 (11.9–24.9)

 < 18.5

77 (48.4)

38 (28.6)

Serum creatinine (mg/dL)

0.64 (0.22–3.00)

0.69 (0.24–5.68)

 < 0.60

67 (42.1)

40 (30.1)

Estimated creatinine clearance (mL/min)

51.5 (9.7–121.2)

50.9 (7.7–110.6)

 ≤ 50.0

75 (47.2)

63 (47.4)

The glomerular filtration rate estimated from creatinine (mL/min)

65.5 (12.4–159.1)

68.4 (7.5–195.4)

 ≤ 50.0

45 (28.3)

25 (18.8)

Serum albumin (g/dL)

2.3 (1.2–4.2)

2.5 (1.2–4.4)

 < 2.0

31 (19.5)

19 (14.3)

 2.0–2.9

113 (71.1)

85 (63.9)

 3.0–3.5

9 (5.7)

19 (14.3)

 ≥ 3.6

6 (3.8)

10 (7.5)

 Daily maintenance dose of Vancomycin (mg/day)

1500 (250–3000)

1500 (300–3000)

 < 1000

44 (27.7)

31 (23.3)

 1000–2000

108 (67.9)

98 (73.7)

 > 2000

7 (4.4)

4 (3.0)

  1. BMI Body Mass Index, CLcr estimated creatinine clearance, eGFR the glomerular filtration rate estimated from creatinine, VCM Vancomycin